{"id":"NCT00073528","sponsor":"Novartis Pharmaceuticals","briefTitle":"Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Study Comparing GW572016 and Letrozole Versus Letrozole in Subjects With Estrogen/Progesterone Receptor- Positive Advanced or Metastatic Breast Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-12-09","primaryCompletion":"2008-06-03","completion":"2018-03-22","firstPosted":"2003-11-26","resultsPosted":"2012-05-17","lastUpdate":"2021-02-24"},"enrollment":1286,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Breast Neoplasms"],"interventions":[{"type":"DRUG","name":"Lapatinib","otherNames":["GW572016"]},{"type":"DRUG","name":"Letrozole","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo + Letrozole 2.5 mg","type":"PLACEBO_COMPARATOR"},{"label":"Lapatinib 1500 mg + Letrozole 2.5 mg","type":"EXPERIMENTAL"}],"summary":"This study evaluated and compared the efficacy and tolerability of lapatinib and letrozole, with letrozole and placebo in post-menopausal women with hormone receptor positive (ER positive and/or PgR positive) advanced or metastatic breast cancer, who had not received prior therapy for advanced or metastatic disease.","primaryOutcome":{"measure":"Number of Participants With Progression Free Survival (PFS) in the Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced or Metastatic Breast Cancer as Assessed by the Investigator","timeFrame":"From the date of randomization until the date of the first documented progression or date of death from any cause, whichever came first, assessed for up to 46 months","effectByArm":[{"arm":"Placebo + Letrozole 2.5 mg","deltaMin":89,"sd":null},{"arm":"Lapatinib 1500 mg + Letrozole 2.5 mg","deltaMin":88,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.019"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":278,"countries":["United States","Argentina","Australia","Brazil","Bulgaria","Canada","Chile","Colombia","Croatia","Czechia","Denmark","France","Germany","Hungary","Ireland","Italy","Mexico","Netherlands","New Zealand","Pakistan","Peru","Poland","Russia","South Africa","South Korea","Spain","Tunisia","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["19786658","20156908","20798196","24198242","27281556","29522361"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":103,"n":624},"commonTop":["Diarrhoea","Nausea","Rash","Arthralgia","Fatigue"]}}